Member Info for Tommy85

Just going to share the link again found by bp82 earlier, a good read!! https://www.scitecheuropa.eu/lung-cancer-therapeutics-valiseek/88655/

Good read bp:)

Is this Sareum Thoth? Welcome aboard :)

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27893497&ArticleHeadline=Roche_lung_cancer_treatment_gets_marketing_nod_in_China

Just reading the AZN RNS http://www.lse.co.uk/regulatory-news-article.asp?ArticleCode=5dtrpk13&ArticleHeadline=CHMP_recommends_Imfinzi_for_Stage_III_nsclc ‘As part of a broad development programme, Imfinzi is also being tested as a monotherapy and in combination with chemotherapy, radiation therapy, small molecules, and tremelimumab, an anti-CTLA4 monoclonal antibody, as a first or second-line treatment for patients with NSCLC, small cell lung cancer, locally-advanced or metastatic urothelial carcinoma, head and neck cancer and other solid tumours’ Do you think VAL 401 could be seen as a part of a combination with Imfinzi or tremelimumab to produce good results? Apologies about my scientific knowledge I don’t know if 401 could be combined with Imfinzi.

Quite interesting news on Val 401 competition Imfinzi haha http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27794508&ArticleHeadline=AstraZenecas_lung_cancer_treatment_gains_positive_opinion_from_CHMP

Jonjo - http://www.proactiveinvestors.co.uk/companies/stocktube/9901/valirx-plc-enjoying-strong-industry-interest-in-its-cancer-treatments-9901.html

GFB agree with your comments!! Possibly the most exciting time of Vals history, again referring to recent RNS VAL 401 update 14th June 'Advanced conversations have continued with a number of prospective partners with the aim of achieving a partnership, to progress the project appropriately towards eventual patient use'

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=VAL&ArticleCode=5olarfr5&ArticleHeadline=VAL401_Update

With IMM and N4P taking a hammering for failed products, could this be Vals time to shine?!! In fact hang on, the 401 product has proved a success already with commercial chats ongoing!! ATB :)

That's all i did with my broker, iii. ATB

Flipsome, it was actually me who asked the same question, at the same time yesterday

Bloody hell Flipsome give it a rest, you're confusing yourself!!

Well he hasn't sold any shares or we would be notified wouldn't we? So could take that as a sign of confidence

Tozerk, couldn’t give a toss what they earn if they succeed with bringing substantial commercial value to the company :)

Farms = Pharmas, excuse the autocorrect on the iPhone haha

I think before making a decision you need to remember how far the BOD have progressed the compounds, 201 picked up off the floor or a bin in CRUK from 2 Italian scientists (think they are still in for royalties) and 401 a reformulation of risperidrone. They have bought 401 through to a commercial stage discussion now, yes talking commercially!! (details can be found in RNS dated 14th June ''These current and future development updates now focus on the commercial aspects of the completed science development'' we are also due the Clinical Study report which is supposed to be released this month. Dismiss changing management straight away, just delay things by another year and getting even more frustrated. Please find another Bio pharma development company in the UK as advanced as VAL, you simply won't, N4P and IMM have taken an absolute kicking recently due to their products failing at Phase II. 401 is past Phase II with good results on only 8 patients or so, wait until they can open up to a wider audience and hit NSCLC at an earlier stage (this is what the large farms will be interested in) again found in 14th June RNS talking to the advisory board, now we are waiting awaiting commercial negotiations relating to 401. Yes dilution is not great and a bit of a kick in the teeth, but how do companies like VAL exist, through AIM and fundraising. I would rather make some money through more shares in circulation or no money at all with the company going bust, think about your decision! Its a yes from me!! ATB :)

Absolutely jjp! Let’s not all get to hasty tomorrow morning! GLA :)

From what i understand the treatment was Ezutromid in Phase 2 on 40 patients. This was only Phase 2 expected to go into Phase 3. SP trading at £2.65 back in September, i understand only 85 mill or so shares in issue. With Val 401 have completed phase 2 studies - strongly with a 60% O/S rate and expecting commercial partnership deal on the horizon to go into Phase 3. 0.0265 VAL opposed to £2.65 SUMM or am i completely off track here?

Market all waiting for the next move from Val IMO, lots of investors just waiting on the sidelines, funding or commercial / JV deal on 401? Suzy in Boston with that American geezer (cant remember his name) so talks must be advanced now surely?!!!!

Interesting to see Bristol MS and Merk have developed immunotherapy blockbusters, that fetch $100,000 p.a. From what i understand 401 manufacturing is under $1k, big mark ups for pharmas!! Seems to be some appetite in the market atm.

Whats happening on L2 buddy? Much volume?